Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling system

<p>Abstract</p> <p>Purpose</p> <p>It is still technically difficult to collect high purity cancer cells from tumor tissues, which contain noncancerous cells. We hypothesized that xenograft models of NOG mice expressing enhanced green fluorescent protein (eGFP), referred...

Full description

Bibliographic Details
Main Authors: Shima Kentaro, Mizuma Masamichi, Hayashi Hiroki, Nakagawa Kei, Okada Takaho, Sakata Naoaki, Omura Noriyuki, Kitamura Yo, Motoi Fuyuhiko, Rikiyama Toshiki, Katayose Yu, Egawa Shinichi, Ishii Naoto, Horii Akira, Unno Michiaki
Format: Article
Language:English
Published: BMC 2012-06-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:http://www.jeccr.com/content/31/1/55
id doaj-209be7221ac54b79bd110873a306f768
record_format Article
spelling doaj-209be7221ac54b79bd110873a306f7682020-11-24T22:20:07ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662012-06-013115510.1186/1756-9966-31-55Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling systemShima KentaroMizuma MasamichiHayashi HirokiNakagawa KeiOkada TakahoSakata NaoakiOmura NoriyukiKitamura YoMotoi FuyuhikoRikiyama ToshikiKatayose YuEgawa ShinichiIshii NaotoHorii AkiraUnno Michiaki<p>Abstract</p> <p>Purpose</p> <p>It is still technically difficult to collect high purity cancer cells from tumor tissues, which contain noncancerous cells. We hypothesized that xenograft models of NOG mice expressing enhanced green fluorescent protein (eGFP), referred to as NOG-EGFP mice, may be useful for obtaining such high purity cancer cells for detailed molecular and cellular analyses.</p> <p>Methods</p> <p>Pancreato-biliary cancer cell lines were implanted subcutaneously to compare the tumorigenicity between NOG-EGFP mice and nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice. To obtain high purity cancer cells, the subcutaneous tumors were harvested from the mice and enzymatically dissociated into single-cell suspensions. Then, the cells were sorted by fluorescence-activated cell sorting (FACS) for separation of the host cells and the cancer cells. Thereafter, the contamination rate of host cells in collected cancer cells was quantified by using FACS analysis. The viability of cancer cells after FACS sorting was evaluated by cell culture and subsequent subcutaneous reimplantation in NOG-EGFP mice.</p> <p>Results</p> <p>The tumorigenicity of NOG-EGFP mice was significantly better than that of NOD/SCID mice in all of the analyzed cell lines (<it>p</it> < 0.01). Sorting procedures enabled an almost pure collection of cancer cells with only slight contamination by host cells. Reimplantation of the sorted cancer cells formed tumors again, which demonstrated that cell viability after sorting was well maintained.</p> <p>Conclusions</p> <p>This method provides a novel cancer sampling system for molecular and cellular analysis with high accuracy and should contribute to the development of personalized medicine.</p> http://www.jeccr.com/content/31/1/55NOG-EGFP mouseXenograftCancerStromal cellSeparation
collection DOAJ
language English
format Article
sources DOAJ
author Shima Kentaro
Mizuma Masamichi
Hayashi Hiroki
Nakagawa Kei
Okada Takaho
Sakata Naoaki
Omura Noriyuki
Kitamura Yo
Motoi Fuyuhiko
Rikiyama Toshiki
Katayose Yu
Egawa Shinichi
Ishii Naoto
Horii Akira
Unno Michiaki
spellingShingle Shima Kentaro
Mizuma Masamichi
Hayashi Hiroki
Nakagawa Kei
Okada Takaho
Sakata Naoaki
Omura Noriyuki
Kitamura Yo
Motoi Fuyuhiko
Rikiyama Toshiki
Katayose Yu
Egawa Shinichi
Ishii Naoto
Horii Akira
Unno Michiaki
Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling system
Journal of Experimental & Clinical Cancer Research
NOG-EGFP mouse
Xenograft
Cancer
Stromal cell
Separation
author_facet Shima Kentaro
Mizuma Masamichi
Hayashi Hiroki
Nakagawa Kei
Okada Takaho
Sakata Naoaki
Omura Noriyuki
Kitamura Yo
Motoi Fuyuhiko
Rikiyama Toshiki
Katayose Yu
Egawa Shinichi
Ishii Naoto
Horii Akira
Unno Michiaki
author_sort Shima Kentaro
title Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling system
title_short Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling system
title_full Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling system
title_fullStr Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling system
title_full_unstemmed Potential utility of eGFP-expressing NOG mice (NOG-EGFP) as a high purity cancer sampling system
title_sort potential utility of egfp-expressing nog mice (nog-egfp) as a high purity cancer sampling system
publisher BMC
series Journal of Experimental & Clinical Cancer Research
issn 1756-9966
publishDate 2012-06-01
description <p>Abstract</p> <p>Purpose</p> <p>It is still technically difficult to collect high purity cancer cells from tumor tissues, which contain noncancerous cells. We hypothesized that xenograft models of NOG mice expressing enhanced green fluorescent protein (eGFP), referred to as NOG-EGFP mice, may be useful for obtaining such high purity cancer cells for detailed molecular and cellular analyses.</p> <p>Methods</p> <p>Pancreato-biliary cancer cell lines were implanted subcutaneously to compare the tumorigenicity between NOG-EGFP mice and nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice. To obtain high purity cancer cells, the subcutaneous tumors were harvested from the mice and enzymatically dissociated into single-cell suspensions. Then, the cells were sorted by fluorescence-activated cell sorting (FACS) for separation of the host cells and the cancer cells. Thereafter, the contamination rate of host cells in collected cancer cells was quantified by using FACS analysis. The viability of cancer cells after FACS sorting was evaluated by cell culture and subsequent subcutaneous reimplantation in NOG-EGFP mice.</p> <p>Results</p> <p>The tumorigenicity of NOG-EGFP mice was significantly better than that of NOD/SCID mice in all of the analyzed cell lines (<it>p</it> < 0.01). Sorting procedures enabled an almost pure collection of cancer cells with only slight contamination by host cells. Reimplantation of the sorted cancer cells formed tumors again, which demonstrated that cell viability after sorting was well maintained.</p> <p>Conclusions</p> <p>This method provides a novel cancer sampling system for molecular and cellular analysis with high accuracy and should contribute to the development of personalized medicine.</p>
topic NOG-EGFP mouse
Xenograft
Cancer
Stromal cell
Separation
url http://www.jeccr.com/content/31/1/55
work_keys_str_mv AT shimakentaro potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem
AT mizumamasamichi potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem
AT hayashihiroki potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem
AT nakagawakei potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem
AT okadatakaho potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem
AT sakatanaoaki potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem
AT omuranoriyuki potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem
AT kitamurayo potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem
AT motoifuyuhiko potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem
AT rikiyamatoshiki potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem
AT katayoseyu potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem
AT egawashinichi potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem
AT ishiinaoto potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem
AT horiiakira potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem
AT unnomichiaki potentialutilityofegfpexpressingnogmicenogegfpasahighpuritycancersamplingsystem
_version_ 1725776757302231040